Fernando M. Runzer-Colmenares, Escuela de Medicina, Universidad Científica del Sur, Lima, Perú. Carretera Panamericana Sur 19, Distrito de Villa El Salvador 15067. Mail:
J Nutr Health Aging. 2020;24(9):966-972. doi: 10.1007/s12603-020-1404-6.
Multiple markers are used to assess frailty and vulnerability, conditions associated with the development of chemotherapy toxicity (CTT). However, there is still no consensus on which condition has stronger association with this adverse effect of chemotherapy in the elderly.
To evaluate the association between frailty and vulnerability with the development of CTT in oncogeriatric patients.
DESIGN, SETTING, AND PARTICIPANTS: Through a retrospective cohort, a secondary database of 496 male oncogeriatric military patients treated at the Geriatrics Service of the Naval Medical Centre of Peru during 2013-2015 was analyzed.
With prior informed consent, the presence of frailty, assessed by Fried Phenotype; and vulnerability, assessed by the Vulnerable Elders Survey-13 (VES-13) and G-8, was determined. The follow-up of patients in chemotherapy was performed every 8 weeks, to determine the development of CTT (according to the Common Terminology Criteria for Adverse Events v4.0). In addition, we included sociodemographic characteristics, medical background information and functional assessment variables. The data collected was encoded and imported into STATA v14.0 statistical package for analysis. Multivariate analysis was performed using crude and adjusted Cox regression models. The reported measure was the hazard ratio (HR) with their respective 95% confidence intervals (95%CI).
The average age was 79.2 ± 4.3 years. 129 (26.01%) developed CTT during follow-up. Similarly, 129 older adults (26.01%) were positive for frailty according to Fried phenotype; 101 (20.36%) were positive for vulnerability with VES-13, and 112 (22.58%) with G-8. In the adjusted Cox model, by type of cancer and adverse effects, a statistically significant association was found between the 3 scales evaluated and the development of CTT, with the Fried Phenotype as the scale with the strongest association (HR=2.01; 95%CI: 1.04-4.90).
The frailty and vulnerability in the elderly are conditions associated with the development of CTT. The Fried phenotype was the scale with the most significant association with the outcome studied.
多种标志物被用于评估衰弱和脆弱性,这些状况与化疗毒性(CTT)的发展相关。然而,在老年人中,哪种状况与化疗的这种不良影响关联更强,目前仍未达成共识。
评估衰弱和脆弱性与老年肿瘤患者 CTT 发展之间的关系。
设计、地点和参与者:通过回顾性队列研究,对秘鲁海军医疗中心老年科 2013 年至 2015 年期间收治的 496 名男性老年肿瘤患者的二级数据库进行了分析。
在事先获得知情同意的情况下,通过 Fried 表型评估衰弱情况,通过脆弱性评估量表-13(VES-13)和 G-8 评估脆弱性。对接受化疗的患者进行每 8 周的随访,以确定 CTT 的发生(根据不良事件通用术语标准 4.0 版)。此外,我们还纳入了社会人口统计学特征、医疗背景信息和功能评估变量。收集的数据经过编码并导入 STATA v14.0 统计软件包进行分析。使用未调整和调整后的 Cox 回归模型进行多变量分析。报告的测量值为危险比(HR)及其相应的 95%置信区间(95%CI)。
平均年龄为 79.2±4.3 岁。在随访期间,有 129 例(26.01%)患者发生 CTT。同样,根据 Fried 表型,有 129 名老年人(26.01%)为衰弱阳性;101 名(20.36%)老年人 VES-13 阳性,112 名(22.58%)老年人 G-8 阳性。在调整后的 Cox 模型中,按癌症类型和不良反应进行分层,评估的 3 种量表与 CTT 的发生之间存在统计学显著关联,其中 Fried 表型与结局的关联最强(HR=2.01;95%CI:1.04-4.90)。
老年人的衰弱和脆弱性是与 CTT 发展相关的状况。Fried 表型与所研究的结局关联最强。